|Cell line type
|Human induced pluripotent stem cell (hiPSC)
|No similar lines found.
|23rd January 2023
No feedback available yet.
Login to share your feedback, experiences or results with the research community.
|Stanford Cardiovascular Institute (SCVI)
|* Is the cell line readily obtainable for third parties?
General Donor Information
|Age of donor (at collection)
Phenotype and Disease related information (Donor)
|A disease was diagnosed.
|Family history is notable for distant relatives with possible suspicion for HCM
|Is the medical history available upon request?
|Is clinical information available?
|H/o HCM and atrial fibrillation, status postembolic, likely cardioembolic, cerebrovascular event with some residual deficit as well as s/p AV node ablation with permanent pacemaker placement.
|Has the donor karyotype been analysed?
Other Genotyping (Donor)
|Is there genome-wide genotyping or functional data available?
External Databases (Donor)
|Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived?
|Was the consent voluntarily given?
|Has the donor been informed that participation will not directly influence their personal treatment?
|Can you provide us with a copy of the Donor Information Sheet provided to the donor?
|Provide contact information of the holder of the original Donor Information Sheet:
|Do you (Depositor/Provider) hold the original Donor Consent Form?
|If you do not hold the Donor Consent Form, do you know who does?
|Contact information / weblink
|Confirm that consent was obtained by a qualified professional
|Has the donor agreed to be re-contacted?
|Please indicate whether the data associated with the donated material has been pseudonymised or anonymised.
|Does consent explicitly allow the derivation of pluripotent stem cells?
|Does consent expressly prevent the derivation of pluripotent stem cells?
|Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world?
|How may genetic information associated with the cell line be accessed?
|Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample?
|Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions?
|Name of accrediting authority involved?
|Administrative Panel of Human Subjects Research
|For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
|Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
|Age of donor (at collection)
|Passage number reprogrammed
|Is reprogramming vector detectable?
|Files and images showing reprogramming vector expressed or silenced
Vector free reprogramming
|Type of used vector free reprogramming factor(s)
|Derived under xeno-free conditions
|Derived under GMP?
|Available as clinical grade?
Enzyme-free cell dissociation
Base medium: StemMACS IPS Brew
Main protein source: StemMACS 1x supplement
Serum concentration: %
|Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
|Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
|Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Analysis of Undifferentiated Cells
Microbiology / Virus Screening
Karyotyping (Cell Line)
|Has the cell line karyotype been analysed?
Passage number: 15
Karyotyping method: KaryoStat+
Other Genotyping (Cell Line)